Three major scientific controversies about coronavirus
Video: What the huge COVID-19 testing undercount in the US means
Novavax says COVID-19 vaccine could be approved by year-end
Novavax coronavirus vaccine induces immune response in early study
Locking down shape-shifting spike protein aids development of COVID-19 vaccine
What the huge COVID-19 testing undercount in the US means
Novavax coronavirus vaccine induces immune response in early study, shares jump
Researchers develop new mouse model for SARS-CoV-2
NIH launches clinical trial to test antibody treatment in hospitalized COVID-19 patients
How many people are now immune to SARS-CoV-2?
Next big COVID-19 treatment may be manufactured antibodies
COVID-19 Vaccine Could Mean Regular Injections, No Guarantee Of Immunity
RSV vaccination of pregnant women could prevent pneumonia in babies
Overcoming Scale-Up Challenges in Gene Therapy Manufacturing
Fully Automated Luxury Drug Discovery
Coronavirus vaccine: lessons from the 19th-century smallpox anti-vaxxer movement
Coronavirus pharma news roundup – 31/07/20
Re-engineering antibodies for COVID-19
Johnson & Johnson starts human study of Covid-19 vaccine
Rapid test for the determination of antibodies against Sars-Cov-2
Single-shot COVID-19 vaccine protects non-human primates
Bill Gates discusses the coronavirus death rate
Johnson & Johnson Starts First Human Trials For Its Covid-19 Candidate
Can llama antibodies beat COVID-19? Belgium’s ExeVir raises 23m euros to find out
Experimental COVID-19 vaccine protects upper and lower airways in nonhuman primates
Americans Aren't That Worried About Returning To Work Amid COVID-19
After Big Pharma abandoned infectious diseases, 5 biotech contrarians decided to go all in. Then Covid-19 changed everything
Pitt collaborative receives $7 million for COVID-19 outpatient convalescent plasma therapy
New affinity purification technique for therapeutic proteins
UArizona aims to provide rapid tests for those exposed to biothreats, such as COVID-19